Medication info

Zansiqu (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White circular film-coated tablet
Packaging
100 tablets (10 tablets/Alu-Alu x 10)
Approval status
Expired

MFDS item code 200401474 · Notified 2004.04.26

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, etc.), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer ranitidine 150 mg per dose orally twice a day, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine per dose orally twice a day, or 300 mg once a day at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg per dose twice a day, in the morning and at bedtime. The dosage and administration are the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once a day at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg per dose twice a day for 8 weeks, or 300 mg once a day at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times a day. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg per dose 3 times a day, and increase the dose if necessary. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration and administer 150 mg per dose twice a day. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, erythema, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once a day at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once a day at bedtime. The dosing interval may be extended to 12 hours or longer, depending on the patient's condition. Hemodialysis decreases the blood concentration of the medicine, so adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
Excess stomach acid, heartburn, acid regurgitation: For patients 12 years and older, administer 75 mg of this medicine orally twice a day (oral solution only). For ages 8 〜 18 years, 150 mg per dose (2 mg/kg of body weight) may be administered up to twice a day.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, etc.), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Stomach and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • preoperative medication (prevention of Mendelson syndrome)
  • postoperative ulcers
  • stomach and duodenal ulcers caused by non-steroidal anti-inflammatory drug (NSAID) administration
  • gastric mucosal lesions (erosion
  • bleeding
  • redness
  • swelling)
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication is effective for gastrointestinal diseases such as stomach and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent Mendelson syndrome that can occur during the preoperative anesthesia process and aids in the prevention of postoperative ulcers. It is also used to treat ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is effective in improving upper gastrointestinal bleeding lesions such as acute exacerbation of acute and chronic gastritis, and gastric mucosal bleeding. In addition, it helps relieve symptoms of heartburn and regurgitation due to excessive gastric acid. This drug improves symptoms of various gastrointestinal-related diseases.

How to take

Adult dose

(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer ranitidine 150 mg per dose orally twice a day, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine per dose orally twice a day, or 300 mg once a day at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg per dose twice a day, in the morning and at bedtime. The dosage and administration are the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once a day at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg per dose twice a day for 8 weeks, or 300 mg once a day at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times a day. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg per dose 3 times a day, and increase the dose if necessary. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration and administer 150 mg per dose twice a day. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, erythema, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once a day at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once a day at bedtime. The dosing interval may be extended to 12 hours or longer, depending on the patient's condition. Hemodialysis decreases the blood concentration of the medicine, so adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

Excess stomach acid, heartburn, acid regurgitation: For patients 12 years and older, administer 75 mg of this medicine orally twice a day (oral solution only). For ages 8 〜 18 years, 150 mg per dose (2 mg/kg of body weight) may be administered up to twice a day.

Precautions

This drug should not be used in patients who have had an allergic reaction to any component of this drug or have a history of acute porphyria. Patients with impaired kidney function may require dose reduction or an increase in dosing intervals due to the potential for increased plasma drug concentration. Caution is advised in patients with impaired liver function or a history of drug allergies, the elderly, and those taking non-steroidal anti-inflammatory drugs. Particularly, the symptoms of stomach cancer may be masked, so patients with stomach ulcers or new indigestion symptoms in middle-aged or older individuals should be administered only after confirming malignancy. If hypersensitivity symptoms such as shock, rash, or difficulty breathing occur during the use of this drug, it should be discontinued immediately and a physician should be consulted. Rarely, various side effects such as abnormal blood tests, liver dysfunction, cardiac rhythm abnormalities, gastrointestinal symptoms, and neurological symptoms may occur; if symptoms develop, medical personnel should be notified immediately. During treatment, regular blood tests and liver and kidney function tests should be conducted, and if there is no effect, it may be beneficial to switch to another treatment modality. Elderly patients or those with chronic pulmonary disease or diabetes should be cautious as the risk of pneumonia may be increased. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This drug may interact with others; if there are other medications being taken, it is essential to inform medical staff, particularly if anticoagulants are being consumed, and closely monitor blood coagulation status. Women who are pregnant or nursing should consult a physician to carefully consider the benefits and risks of administering this drug. Safety in children has not been fully verified, so a cautious approach should be taken when administering to children. There have been no significant severe problems reported from overdose; however, appropriate treatment may be needed, such as vomiting or gastric lavage. This drug should be kept out of reach of children and it is advisable not to transfer it to other containers. It is recommended to undergo eye examinations during long-term use, and caution should also be taken due to the possibility of bacterial overgrowth in the stomach due to decreased gastric acid secretion.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine levels
Show 58 more
  • leukopenia
  • thrombocytopenia
  • hypoplastic bone marrow syndrome
  • aplastic anemia
  • aplastic anemia
  • myelodysplastic syndrome
  • hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • subconjunctival bleeding
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • liver-related muscle cramps
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air ingress, and it is advisable to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

White circular film-coated tablet

Package unit

100 tablets (10 tablets/Alu-Alu x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.